# Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)

> **NCT05409222** · — · UNKNOWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 45 (estimated)

## Conditions studied

- Hereditary Breast and Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05409222
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-12
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05409222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05409222, "Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05409222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*